Cargando…

Extracellular Vesicles Are More Potent Than Adipose Mesenchymal Stromal Cells to Exert an Anti-Fibrotic Effect in an In Vitro Model of Systemic Sclerosis

Systemic sclerosis (SSc) is a complex disorder resulting from dysregulated interactions between the three main pathophysiological axes: fibrosis, immune dysfunction, and vasculopathy, with no specific treatment available to date. Adipose tissue-derived mesenchymal stromal cells (ASCs) and their extr...

Descripción completa

Detalles Bibliográficos
Autores principales: Rozier, Pauline, Maumus, Marie, Bony, Claire, Maria, Alexandre Thibault Jacques, Sabatier, Florence, Jorgensen, Christian, Guilpain, Philippe, Noël, Danièle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269376/
https://www.ncbi.nlm.nih.gov/pubmed/34202139
http://dx.doi.org/10.3390/ijms22136837
_version_ 1783720565630042112
author Rozier, Pauline
Maumus, Marie
Bony, Claire
Maria, Alexandre Thibault Jacques
Sabatier, Florence
Jorgensen, Christian
Guilpain, Philippe
Noël, Danièle
author_facet Rozier, Pauline
Maumus, Marie
Bony, Claire
Maria, Alexandre Thibault Jacques
Sabatier, Florence
Jorgensen, Christian
Guilpain, Philippe
Noël, Danièle
author_sort Rozier, Pauline
collection PubMed
description Systemic sclerosis (SSc) is a complex disorder resulting from dysregulated interactions between the three main pathophysiological axes: fibrosis, immune dysfunction, and vasculopathy, with no specific treatment available to date. Adipose tissue-derived mesenchymal stromal cells (ASCs) and their extracellular vesicles (EVs) have proved efficacy in pre-clinical murine models of SSc. However, their precise action mechanism is still not fully understood. Because of the lack of availability of fibroblasts isolated from SSc patients (SSc-Fb), our aim was to determine whether a TGFβ1-induced model of human myofibroblasts (Tβ-Fb) could reproduce the characteristics of SSc-Fb and be used to evaluate the anti-fibrotic function of ASCs and their EVs. We found out that Tβ-Fb displayed the main morphological and molecular features of SSc-Fb, including the enlarged hypertrophic morphology and expression of several markers associated with the myofibroblastic phenotype. Using this model, we showed that ASCs were able to regulate the expression of most myofibroblastic markers on Tβ-Fb and SSc-Fb, but only when pre-stimulated with TGFβ1. Of interest, ASC-derived EVs were more effective than parental cells for improving the myofibroblastic phenotype. In conclusion, we provided evidence that Tβ-Fb are a relevant model to mimic the main characteristics of SSc fibroblasts and investigate the mechanism of action of ASCs. We further reported that ASC-EVs are more effective than parental cells suggesting that the TGFβ1-induced pro-fibrotic environment may alter the function of ASCs.
format Online
Article
Text
id pubmed-8269376
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82693762021-07-10 Extracellular Vesicles Are More Potent Than Adipose Mesenchymal Stromal Cells to Exert an Anti-Fibrotic Effect in an In Vitro Model of Systemic Sclerosis Rozier, Pauline Maumus, Marie Bony, Claire Maria, Alexandre Thibault Jacques Sabatier, Florence Jorgensen, Christian Guilpain, Philippe Noël, Danièle Int J Mol Sci Article Systemic sclerosis (SSc) is a complex disorder resulting from dysregulated interactions between the three main pathophysiological axes: fibrosis, immune dysfunction, and vasculopathy, with no specific treatment available to date. Adipose tissue-derived mesenchymal stromal cells (ASCs) and their extracellular vesicles (EVs) have proved efficacy in pre-clinical murine models of SSc. However, their precise action mechanism is still not fully understood. Because of the lack of availability of fibroblasts isolated from SSc patients (SSc-Fb), our aim was to determine whether a TGFβ1-induced model of human myofibroblasts (Tβ-Fb) could reproduce the characteristics of SSc-Fb and be used to evaluate the anti-fibrotic function of ASCs and their EVs. We found out that Tβ-Fb displayed the main morphological and molecular features of SSc-Fb, including the enlarged hypertrophic morphology and expression of several markers associated with the myofibroblastic phenotype. Using this model, we showed that ASCs were able to regulate the expression of most myofibroblastic markers on Tβ-Fb and SSc-Fb, but only when pre-stimulated with TGFβ1. Of interest, ASC-derived EVs were more effective than parental cells for improving the myofibroblastic phenotype. In conclusion, we provided evidence that Tβ-Fb are a relevant model to mimic the main characteristics of SSc fibroblasts and investigate the mechanism of action of ASCs. We further reported that ASC-EVs are more effective than parental cells suggesting that the TGFβ1-induced pro-fibrotic environment may alter the function of ASCs. MDPI 2021-06-25 /pmc/articles/PMC8269376/ /pubmed/34202139 http://dx.doi.org/10.3390/ijms22136837 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Rozier, Pauline
Maumus, Marie
Bony, Claire
Maria, Alexandre Thibault Jacques
Sabatier, Florence
Jorgensen, Christian
Guilpain, Philippe
Noël, Danièle
Extracellular Vesicles Are More Potent Than Adipose Mesenchymal Stromal Cells to Exert an Anti-Fibrotic Effect in an In Vitro Model of Systemic Sclerosis
title Extracellular Vesicles Are More Potent Than Adipose Mesenchymal Stromal Cells to Exert an Anti-Fibrotic Effect in an In Vitro Model of Systemic Sclerosis
title_full Extracellular Vesicles Are More Potent Than Adipose Mesenchymal Stromal Cells to Exert an Anti-Fibrotic Effect in an In Vitro Model of Systemic Sclerosis
title_fullStr Extracellular Vesicles Are More Potent Than Adipose Mesenchymal Stromal Cells to Exert an Anti-Fibrotic Effect in an In Vitro Model of Systemic Sclerosis
title_full_unstemmed Extracellular Vesicles Are More Potent Than Adipose Mesenchymal Stromal Cells to Exert an Anti-Fibrotic Effect in an In Vitro Model of Systemic Sclerosis
title_short Extracellular Vesicles Are More Potent Than Adipose Mesenchymal Stromal Cells to Exert an Anti-Fibrotic Effect in an In Vitro Model of Systemic Sclerosis
title_sort extracellular vesicles are more potent than adipose mesenchymal stromal cells to exert an anti-fibrotic effect in an in vitro model of systemic sclerosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269376/
https://www.ncbi.nlm.nih.gov/pubmed/34202139
http://dx.doi.org/10.3390/ijms22136837
work_keys_str_mv AT rozierpauline extracellularvesiclesaremorepotentthanadiposemesenchymalstromalcellstoexertanantifibroticeffectinaninvitromodelofsystemicsclerosis
AT maumusmarie extracellularvesiclesaremorepotentthanadiposemesenchymalstromalcellstoexertanantifibroticeffectinaninvitromodelofsystemicsclerosis
AT bonyclaire extracellularvesiclesaremorepotentthanadiposemesenchymalstromalcellstoexertanantifibroticeffectinaninvitromodelofsystemicsclerosis
AT mariaalexandrethibaultjacques extracellularvesiclesaremorepotentthanadiposemesenchymalstromalcellstoexertanantifibroticeffectinaninvitromodelofsystemicsclerosis
AT sabatierflorence extracellularvesiclesaremorepotentthanadiposemesenchymalstromalcellstoexertanantifibroticeffectinaninvitromodelofsystemicsclerosis
AT jorgensenchristian extracellularvesiclesaremorepotentthanadiposemesenchymalstromalcellstoexertanantifibroticeffectinaninvitromodelofsystemicsclerosis
AT guilpainphilippe extracellularvesiclesaremorepotentthanadiposemesenchymalstromalcellstoexertanantifibroticeffectinaninvitromodelofsystemicsclerosis
AT noeldaniele extracellularvesiclesaremorepotentthanadiposemesenchymalstromalcellstoexertanantifibroticeffectinaninvitromodelofsystemicsclerosis